본문으로 건너뛰기
← 뒤로

Limbic encephalitis associated with anti-Hu antibody induced by atezolizumab treatment for small cell lung cancer: A case report.

Oncology letters 2026 Vol.31(5) p. 177 🌐 cited 1 🔓 OA Autoimmune Neurological Disorders an
OpenAlex 토픽 · Autoimmune Neurological Disorders and Treatments Cancer Immunotherapy and Biomarkers Cytomegalovirus and herpesvirus research

Li Z, Wang H

📝 환자 설명용 한 줄

With the emergence and frequent use of immune checkpoint inhibitors (ICIs), reports of immunotherapy-induced limbic encephalitis have begun to appear.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Zhaohui Li, Hanping Wang (2026). Limbic encephalitis associated with anti-Hu antibody induced by atezolizumab treatment for small cell lung cancer: A case report.. Oncology letters, 31(5), 177. https://doi.org/10.3892/ol.2026.15532
MLA Zhaohui Li, et al.. "Limbic encephalitis associated with anti-Hu antibody induced by atezolizumab treatment for small cell lung cancer: A case report.." Oncology letters, vol. 31, no. 5, 2026, pp. 177.
PMID 41918809

Abstract

With the emergence and frequent use of immune checkpoint inhibitors (ICIs), reports of immunotherapy-induced limbic encephalitis have begun to appear. The present study describes the case of a patient with small cell lung cancer who developed Hu-associated limbic encephalitis while being treated with atezolizumab. After treatment with high-dose steroids and intravenous immunoglobulin, the neurological symptoms of the patient (including confusion, short-term memory loss, disorientation, and impaired calculation ability) remained stable for 3 months, after which the patient was lost to follow-up. ICIs may accelerate autoimmune reactions that target paraneoplastic origin autoantigens. Clinicians should be alert to the risk of ICI-induced paraneoplastic neurological syndromes in patients with tumors, such as small cell lung cancer, that are traditionally associated with paraneoplastic neurological syndromes.

같은 제1저자의 인용 많은 논문 (5)